V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20024710 | 20010493 | null | null | Neo-adjuvant (N) | 2014-06-15 | 2014-06-23 | FEC + DOCETAXEL | N | null | 20087333 | FEC + DOCETAXEL |
| 20024711 | 20010493 | null | null | Adjuvant (A) | 2014-05-22 | 2014-06-07 | FEC + DOCETAXEL | 2 | null | 20087333 | FEC + DOCETAXEL |
| 20024714 | 20010495 | 1.58 | 103 | Adjuvant (A) | 2017-11-05 | 2017-11-09 | FEC 100 + DOCETAXEL | N | N | 20087348 | FEC + DOCETAXEL |
| 20024715 | 20010496 | 1.73 | 69.7 | Not known (9) | 2013-09-22 | 2013-09-23 | FEC + DOCETAXEL | N | N | 20087351 | FEC + DOCETAXEL |
| 20024716 | 20071093 | 1.6 | 67.3 | Adjuvant (A) | 2016-07-27 | 2016-07-27 | FEC + DOCETAXEL | 02 | N | 20087358 | FEC + DOCETAXEL |
| 20024717 | 20010497 | 1.6 | null | Adjuvant (A) | 2016-05-02 | 2016-05-17 | FEC 100 + DOCETAXEL | N | null | 20087360 | FEC + DOCETAXEL |
| 20024718 | 20010497 | null | null | null | 2015-03-11 | 2015-03-25 | FEC 100 + DOCETAXEL | N | N | 20087360 | FEC + DOCETAXEL |
| 20024719 | 20010498 | 1.51 | 70.7 | Adjuvant (A) | 2016-12-17 | 2016-12-18 | FEC + DOCETAXEL | 02 | N | 20087367 | FEC + DOCETAXEL |
| 20024720 | 20010498 | 1.61 | 59.05 | Curative (C) | 2015-12-14 | 2015-12-14 | FEC + DOCETAXEL | 02 | N | 20087367 | FEC + DOCETAXEL |
| 20024721 | 20010498 | 1.73 | 92 | Curative (C) | 2016-04-17 | 2016-04-20 | FEC + DOCETAXEL | 01 | N | 20087367 | FEC + DOCETAXEL |
| 20024722 | 20010499 | 1.55 | 50 | Disease modification (D) | 2014-08-18 | 2014-08-18 | FEC + DOCETAXEL | 02 | N | 20087381 | FEC + DOCETAXEL |
| 20024723 | 20010500 | 1.5 | 76 | Adjuvant (A) | 2014-10-11 | 2014-10-12 | FEC + DOCETAXEL | 02 | Y | 20087382 | FEC + DOCETAXEL |
| 20024724 | 20010500 | null | 63.1 | null | 2015-07-28 | 2015-08-11 | FEC 100 + DOCETAXEL | N | N | 20087382 | FEC + DOCETAXEL |
| 20024725 | 20010501 | null | null | Neo-adjuvant (N) | 2015-02-10 | 2015-03-06 | FEC + DOCETAXEL | N | N | 20087385 | FEC + DOCETAXEL |
| 20024726 | 20071097 | 1.64 | 69 | null | 2015-03-16 | 2015-03-31 | FEC + DOCETAXEL | N | N | 20087387 | FEC + DOCETAXEL |
| 20024727 | 20108520 | 1.52 | 79.6 | Adjuvant (A) | 2014-03-12 | 2014-03-23 | FEC 100 + DOCETAXEL | N | N | 20087391 | FEC + DOCETAXEL |
| 20024728 | 20108520 | null | null | Adjuvant (A) | 2014-04-08 | 2014-04-19 | FEC 100 + DOCETAXEL | N | N | 20087391 | FEC + DOCETAXEL |
| 20024729 | 20108520 | 1.63 | 70.5 | Adjuvant (A) | 2015-11-09 | 2015-11-24 | FEC + DOCETAXEL | N | N | 20087391 | FEC + DOCETAXEL |
| 20024730 | 20143088 | 1.61 | 76.2 | Adjuvant (A) | 2016-02-02 | 2016-02-02 | FEC 100 + DOCETAXEL | 2 | N | 20087400 | FEC + DOCETAXEL |
| 20024731 | 20143088 | 1.52 | null | Adjuvant (A) | 2015-08-20 | 2015-09-01 | FEC 100 + DOCETAXEL | N | N | 20087400 | FEC + DOCETAXEL |
| 20024732 | 20143088 | 1.63 | 71 | Adjuvant (A) | 2016-06-07 | 2016-06-13 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20087400 | FEC + DOCETAXEL |
| 20024733 | 20010502 | null | 79.6 | Adjuvant (A) | 2016-12-24 | 2016-12-29 | FEC + DOCETAXEL | 2 | N | 20087413 | FEC + DOCETAXEL |
| 20024734 | 20071098 | null | null | Adjuvant (A) | 2015-01-27 | 2015-02-13 | FEC + DOCETAXEL | N | N | 20087416 | FEC + DOCETAXEL |
| 20024735 | 20010503 | null | 60 | Curative (C) | 2017-03-07 | 2017-03-24 | FEC + DOCETAXEL | 02 | N | 20087420 | FEC + DOCETAXEL |
| 20024736 | 20010503 | 1.47 | 49 | Adjuvant (A) | 2013-11-17 | 2013-11-21 | FEC + DOCETAXEL | 02 | N | 20087420 | FEC + DOCETAXEL |
| 20024737 | 20010503 | null | 95.4 | Neo-adjuvant (N) | 2016-08-29 | 2016-09-07 | FEC + DOCETAXEL | 2 | N | 20087420 | FEC + DOCETAXEL |
| 20024738 | 20127777 | 0 | 82.4 | Adjuvant (A) | 2014-07-24 | 2014-07-26 | FEC + DOCETAXEL | 02 | N | 20087430 | FEC + DOCETAXEL |
| 20024739 | 20127777 | 1.66 | 73 | Adjuvant (A) | 2013-05-16 | 2013-05-30 | FEC + DOCETAXEL | 2 | null | 20087430 | FEC + DOCETAXEL |
| 20024740 | 20127777 | null | 72 | Adjuvant (A) | 2014-01-28 | 2014-02-03 | FEC 100 + DOCETAXEL | N | N | 20087430 | FEC + DOCETAXEL |
| 20024741 | 20010504 | 1.67 | 89.8 | Adjuvant (A) | 2018-04-08 | 2018-04-23 | FEC + DOCETAXEL | 02 | N | 20087438 | FEC + DOCETAXEL |
| 20024742 | 20010504 | 1.62 | 92 | Neo-adjuvant (N) | 2015-11-24 | 2015-12-02 | FEC + DOCETAXEL | 02 | N | 20087438 | FEC + DOCETAXEL |
| 20024743 | 20010504 | 1.69 | 102 | Neo-adjuvant (N) | 2017-03-24 | 2017-03-31 | FEC + DOCETAXEL | 02 | N | 20087438 | FEC + DOCETAXEL |
| 20024744 | 20010504 | 1.64 | 109.5 | Curative (C) | 2015-02-03 | 2015-02-03 | FEC + DOCETAXEL | 02 | N | 20087438 | FEC + DOCETAXEL |
| 20024745 | 20010505 | 1.67 | 54.55 | Adjuvant (A) | 2014-01-18 | 2014-01-18 | FEC + DOCETAXEL | 2 | Y | 20087451 | FEC + DOCETAXEL |
| 20024746 | 20071101 | 1.61 | 72.7 | Adjuvant (A) | 2013-08-30 | 2013-09-15 | FEC 100 + DOCETAXEL | N | N | 20087453 | FEC + DOCETAXEL |
| 20024747 | 20071101 | 0.1 | 56 | Neo-adjuvant (N) | 2017-01-03 | 2017-01-05 | FEC + DOCETAXEL | 2 | N | 20087453 | FEC + DOCETAXEL |
| 20024748 | 20071101 | 1.66 | 98 | Adjuvant (A) | 2014-02-23 | 2014-02-23 | FEC 100 + DOCETAXEL | 2 | N | 20087453 | FEC + DOCETAXEL |
| 20024749 | 20010506 | 1.6 | 67.2 | Adjuvant (A) | 2015-10-18 | 2015-12-23 | FEC + DOCETAXEL | 02 | N | 20087461 | FEC + DOCETAXEL |
| 20024750 | 20071102 | 1.56 | 70.9 | Curative (C) | 2016-09-20 | 2016-10-08 | FEC + DOCETAXEL | 02 | N | 20087464 | FEC + DOCETAXEL |
| 20024751 | 20010507 | 1.6 | null | Neo-adjuvant (N) | 2014-12-30 | 2015-01-14 | FEC + DOCETAXEL | null | null | 20087465 | FEC + DOCETAXEL |
| 20024752 | 20010507 | 1.65 | 84 | Adjuvant (A) | 2015-04-19 | 2015-07-15 | FEC 100 + DOCETAXEL | 2 | N | 20087465 | FEC + DOCETAXEL |
| 20024753 | 20010507 | 1.53 | 73.8 | Adjuvant (A) | null | 2015-11-11 | FEC + DOCETAXEL | N | null | 20087465 | FEC + DOCETAXEL |
| 20024754 | 20010508 | 0.1 | 71.9 | Neo-adjuvant (N) | 2014-03-20 | 2014-03-20 | FEC + DOCETAXEL | 02 | N | 20087470 | FEC + DOCETAXEL |
| 20024755 | 20010508 | 1.7 | 59 | Neo-adjuvant (N) | 2014-07-01 | 2014-07-02 | FEC + DOCETAXEL | 02 | null | 20087470 | FEC + DOCETAXEL |
| 20024756 | 20010509 | 1.7 | 69.2 | Adjuvant (A) | 2016-08-14 | 2016-08-19 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20087473 | FEC + DOCETAXEL |
| 20024757 | 20010509 | 1.7 | 64 | Palliative (P) | 2015-10-25 | 2015-10-29 | FEC + DOCETAXEL | 02 | N | 20087473 | FEC + DOCETAXEL |
| 20024758 | 20010510 | 1.66 | 77 | Adjuvant (A) | 2016-05-16 | 2016-07-02 | FEC + DOCETAXEL | N | N | 20087483 | FEC + DOCETAXEL |
| 20024759 | 20010511 | 1.73 | null | Adjuvant (A) | 2015-12-31 | 2016-03-16 | FEC + DOCETAXEL | N | N | 20087484 | FEC + DOCETAXEL |
| 20024760 | 20071106 | 1.68 | 74.2 | Adjuvant (A) | 2017-01-01 | 2017-01-01 | FEC + DOCETAXEL | 02 | N | 20087486 | FEC + DOCETAXEL |
| 20024761 | 20010512 | 1.5 | 79 | Not known (9) | null | 2015-03-17 | FEC + DOCETAXEL | N | N | 20087490 | FEC + DOCETAXEL |